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 Chronic progressive kidney disease is 
histologically characterized by the triad 
of glomerulosclerosis, tubular atrophy, 
and interstitial . brosis. Such . brosis in 
the kidney is characterized by accumula-
tion of . broblasts, excessive deposition 
of extracellular matrix, mononuclear 
in. ltrate, and rarefaction of the peritu-
bular microvasculature. Despite the con-
sensus on what a . brotic kidney looks 
like, there is an ongoing debate on what 
the key mechanisms are that drive the 
. brotic process. 1 Transforming growth 
factor-  1 (TGF-  1) is currently the best-
established profibrotic stimulus, as 
numerous studies have unequivocally 
demonstrated that an abundance of 
TGF-  1 signaling can recapitulate all 
the major features of tubulointerstitial 
 fibrosis in rodent models of chronic 
 kidney disease. Nevertheless, evidence is 
increasing that demonstrates key roles 
for TGF-  1-independent mechanisms in 
renal . brogenesis as well. 
 Chronic hypoxia is increasingly being 
recognized as an important  determinant 
of fibrosis in the kidney. 2 Although 
 peritubular microvascular rarefaction has 
long been established as a histopatho-
logical component of tubulointerstitial 
 fibrosis, there has been a debate as to 
whether this was a cause or an e ect of 
renal fibrogenesis. However, in recent 
years,  mechanistic evidence has increas-
ingly demonstrated that chronic hypoxia 
(as it is caused by microvascular rarefac-
tion) is an important contributor to . bro-
sis in the kidney. 
 Epithelial-to-mesenchymal transition 
(EMT) is one component of interstitial 
. brosis that exempli. es the emergence of 
chronic hypoxia as a key pro. brotic stim-
ulus. EMT is a transcriptional program 
that induces acquisition of a mesenchymal 
phenotype in epithelioid cells. First dis-
covered in embryonic development, the 
EMT program is now known to induce 
acquisition of a mesenchymal phenotype 
and resistance to proapoptotic stimuli in 
cancer cells (facilitating tumor invasion 
and metastasis) and adult epithelia (facil-
itating . brogenesis) as it does in primary 
and secondary epithelia during embryo-
genesis. 
 Stimuli that can induce EMT are mani-
fold, and signaling pathways involved in 
the EMT program are vast and complex; 
as a result, identi. cation of  ‘ master regula-
tors ’ of EMT is highly relevant. 3 In the 
setting of cancer metastasis, EMT master 
regulators include the transcription fac-
tors Snail and ZEB1 (which are induced 
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 Sun  et al. demonstrate that hypoxia causes epithelial-to-mesenchymal 
transition by activating Twist, a transcription factor known to mediate 
both acquisition of a mesenchymal phenotype and resistance to 
apoptosis in cancer cells. This study provides clues as to how hypoxia 
and transforming growth factor-  can collaborate to drive renal 
fibrogenesis. 
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by TGF-  1) and Twist (which is TGF-  1 
independent). Until now, all established 
inducers of EMT in the renal . brosis set-
ting have acted through either Snail or 
ZEB1 / 2. 
 In the renal . brosis setting, the best-
established inducer of an EMT program 
is TGF-  1, which induces Snail1 activa-
tion in a Smad-dependent manner 
 ( Figure 1 ), and in recent years, . brosis-
related EMT research has centered on 
TGF-  1. Although it is well established 
that hypoxia induces EMT in cancer cells, 
such evidence has been lacking in the con-
text of . brosis involving adult epithelia. 
 Manotham and co-workers reported 
that tubular epithelial cells respond to 
hypoxia  in vitro by undergoing EMT. 4  e 
relevance of hypoxia-induced EMT in the 
renal . brosis setting was further corrobo-
rated by Higgins  et al. , who used condi-
tional hypoxia-inducible factor-1  
(HIF-1  )-de. cient mice to demonstrate 
that hypoxia induces EMT involving 
tubular epithelial cells via HIF-1 signaling 
and that such hypoxia-induced HIF-1-
dependent EMT contributes to renal 
. brogenesis. 5  ey suggested that such 
HIF-1-induced EMT was partially medi-
ated by accumulation of lysyl oxidases 
(LOX and LOX2), ultimately leading to 
Snail1 activation and EMT. 
 Sun and co-workers 6 (this issue) now 
demonstrate a role for Twist activation by 
HIF-1 in hypoxia-induced EMT.  ey 
demonstrate that hypoxia-induced EMT 
 in vitro is associated with increased HIF-
1  and Twist expression, that knock-
down of either HIF-1  or Twist blocks 
hypoxia-induced EMT, and that overex-
pression of either HIF-1  (which induces 
Twist expression) or Twist mimics 
hypoxia-induced EMT. Using various 
Twist promoter deletion constructs, they 
demonstrate that hypoxia-induced Twist 
expression is mediated by hypoxia-
response elements in the proximal Twist 
promoter region. By chromatin immuno-
precipitation assay and electrophoretic 
mobility shi?  assay, they verify that bind-
ing of HIF-1 to the hypoxia-response ele-
ment located at   −  317 to   −  312 directly 
induces Twist expression.  ey underline 
their  in vitro findings with an  in vivo 
study in the mouse model of 5 / 6 nephrec-
tomy, showing HIF-1  and Twist to be 
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 . brosis setting but also for cancer progres-
sion, as a role of Twist in EMT involving 
cancer cells is well established. Future 
studies will need to determine whether 
Twist inhibition will have an e ect on a 
broad spectrum of pathologies. 
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signi. cantly upregulated in tubular epi-
thelial cells undergoing EMT. Even 
though they do not provide direct evi-
dence that Twist activation in tubular 
epithelial cells causes EMT and . brosis 
 in vivo (as was demonstrated for Snail), this 
study is highly suggestive that Twist activa-
tion contributes to renal . brogenesis. 
 Twist is a basic helix – loop – helix transcrip-
tion factor that is essential for gastrulation 
and mesoderm di erentiation during early 
embryogenesis. 7 Recent studies highlighted 
a role for Twist in cancer metastasis, as Twist 
activation induces EMT in cancer cells, and 
increased Twist expression is associated with 
worse outcome in cancer patients. 8 As 
opposed to Snail, Twist antagonizes apopto-
sis and cell-cycle arrest in cancer cells, in 
addition to inducing the acquisition of a 
mesenchymal phenotype. 9,10 
  e study by Sun  et al. 6 is the . rst report 
of Twist involvement in EMT associated 
with . brosis. Evidence for involvement of 
Twist activation in EMT associated with 
kidney . brosis is relevant because Twist 
activation possibly presents an alternative 
or additional pathway to the established 
pathways that converge through Snail sig-
naling ( Figure 1 ). Given what is known 
from the cancer literature, Twist activation 
could possibly clarify the additive e ect of 
epidermal growth factor on TGF-
  1-induced EMT (Twist is activated by 
epidermal growth factor) and the resist-
ance to apoptosis and increased prolifera-
tive activity of tubular epithelial cells in 
renal fibrosis, which could not be 
explained until now. 
 An understanding of how hypoxia 
 regulates Twist is relevant not only in the 
 Figure 1  |  Major pathways of EMT. Chronic hypoxia and TGF-  1 are major environmental stimuli 
that induce EMT in adult epithelia and cancer cells. Twist, Snail, and ZEB1 are master regulators 
of the EMT transcriptional program. Activation of Twist, Snail, or ZEB1 is sufficient to induce 
a mesenchymal phenotype. In addition, Twist also protects cells from apoptotic stimuli and 
inactivates cellular senescence in cancer cells. Hypoxia-induced EMT is mediated by HIF-1 / 2 via 
Twist and Snail. TGF-  1-induced EMT is mediated by ZEB1 and Snail in a Smad-dependent manner. 
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